ONCT - Oncternal Therapeutics GAAP EPS of -$3.11 misses by $0.03 revenue of $0.3M beats by $0.16M March, 07 2024 04:02 PM Oncternal Therapeutics Inc. 2024-03-07 16:02:52 ET More on Oncternal Therapeutics Oncternal slips after early data for lymphoma therapy Seeking Alpha’s Quant Rating on Oncternal Therapeutics Historical earnings data for Oncternal Therapeutics Financial information for Oncternal Therapeutics For further details see: Oncternal Therapeutics GAAP EPS of -$3.11 misses by $0.03, revenue of $0.3M beats by $0.16M